Latest long-term debt for ABVC: $1.4M.
Get informed when a big investor buys or sells
+ FollowLatest change versus the prior comparable period (same company).
As of the most recent data (June 2026), ABVC shows a long-term debt of $1.4M. That compares with $180K in the prior-year period — up 693.5% year over year. Scroll down for historical charts and peer comparison views.
Compared with the year-ago period, ABVC's long-term debt is now $1.4M (was $180K) — a 693.5% year-over-year increase. Pairing that YoY change with peer averages gives a clearer picture of whether ABVC BioPharma is outperforming or lagging.
Tracking ABVC's long-term debt over time shows whether ABVC BioPharma is scaling, shrinking, or reshaping that part of the business. The current reading is $1.4M That compares with $180K in the prior-year period — up 693.5% year over year. Multi-quarter patterns matter more than any single print, which is why this page emphasizes history and peer comparison charts.
Besides this long-term debt page, Stockcircle has ABVC BioPharma's full stock overview, other financial metrics, insider and congress trade tabs, and tools to follow the stock. Together they help you connect long-term debt (currently $1.4M) with ownership activity and broader fundamentals.
ABVC BioPharma's long-term debt is $1.4M; compare it with other Industrials names on the peer chart. Typical ranges vary by sub-industry, so always sanity-check against the closest competitors, not just the whole sector bucket.